This finding was reinforced by a very recent study performed in breast cancer cells that demonstrated that taxanes can activate PERK independently of their action on microtubules, and that the activation of the PERK/eIF2α axis is a crucial event for taxane-induced apoptosis. The gene discussed is EIF2A; the disease is breast carcinoma.